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Abstract
Previous studies demonstrated that critically shortened telomere lengths correlate with the chromosome in-
stability in carcinogenesis. However, little has been noticed regarding the correlation of long telomeres at specific
chromosomes with malignant disorders. We studied relative telomere lengths (RTLs) for individual chromosomes
using the quantitative fluorescence in situ hybridization technique in a cohort of 32 patients with chronic myeloid
leukemia (CML) and 32 normal samples. We found that telomeres at some specific chromosome arms remain well
maintained or even lengthened in a high frequency (27/32) of leukemia cases. In particular, 10 chromosome arms,
4q, 5p, 7q, 11p, 13p, 13q, 14p, 15p, 18p, and Xp, with long telomeres were consistently identified in different
samples, and six of them (4q, 5p, 13p, 13q, 14p, and Xp) with relatively long telomeres were also observed in
normal samples, but they appeared in lower occurrence rate and shorter RTL than in CML samples. Our results
strongly indicate the presence of a special leukemia cell population, or a clone, originated from a common progenitor
that is characterized with chromosome arm–specific long telomeres. We suggest that relatively long telomeres
located at key chromosomes could be preferentially maintained or further elongated during the early stage of
malignant transformation.
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Introduction
Human telomeres are long tandem-arrayed stretches of TTAGGG-base
repeat found at the ends of each chromosome arm and are associated
with a variety of telomere-binding proteins [1–5]. These unique ge-
nomic structures help to protect the cell from progressive DNA short-
ening and degradation of the chromosome’s ends that happen during
each round of DNA replication, what is commonly referred to as the
“end-replication problem” [6]. Once telomeres have eroded beyond
a critical length, the cell initiates a coordinated DNA damage signal-
ing response that ultimately ends in a cellular state known as replicative
senescence [7–10]. This is not the case, however, for a majority of
human cancers, where telomerase, the enzyme that polymerizes the
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successive TTAGGG sequence motifs found in telomeres [11], is
highly expressed and confers to the cell a seemingly endless proliferative
capacity or “immortalization” [12–14]. Yet, despite high telomerase
activity, global telomere shortening can still occur in cancer. Shortened
telomeres usually tend to correlate with disease severity such as relapsed
leukemia or high-grade lymphoma [15]. Recent research has shed
new light on the potential of using telomere length as biomarker for
the diagnosis, disease progression, and prognosis for many types of
hematological disorders [15–19].
Telomere length measurements in most previous studies were based
on techniques, such as telomere restriction fragment (TRF) analysis and
fluorescence in situ hybridization (FISH) flow cytometry, which offer a
cruder picture of telomere content by giving average global telomere
lengths. The advent of quantitative fluorescence in situ hybridization
(Q-FISH) has allowed for a more refined study of telomere content
because it can be used to measure telomere lengths for each arm of each
individual chromosome [20]. There have been some studies that have
documented consistent differences in telomere lengths specific to
unique chromosomes [21–24]. One way to explain this is by positing
the involvement of chromosomal specific factors that affect local telo-
mere length regulation [25]. Alternatively, telomerase is known not to
act on every telomere in each cell division with equal activity: rather, it
displays an increasing affinity for telomeres with decreasing length
such that shorter telomeres are elongated first, and thus, this may ex-
plain differences in specific chromosomal telomere lengths [26–28].
However, the presence of long telomeres associated with specific
chromosomes in malignant disorders was somehow overlooked, prob-
ably because most studies focus on the effect of telomere shortening
in tumor.
In the present study, we performed individual telomere length mea-
surements using Q-FISH in primary leukemia cells collected from
32 chronic myeloid leukemia (CML) patients. The CML is a hemato-
logical cancer characterized by the proliferation of myeloid cells that
bear a characteristic genetic marker, the Philadelphia (Ph) chromosome,
which results from the translocation t(9;22)(q34;q11.2) [29]. Com-
pared with other types of cancer, patients with CML have better prog-
nosis and a relatively benign disease course with as much as 90% of
patients surviving at least 5 years when placed on conventional imatinib
therapy [30]. Therefore, it can provide an ideal model for the dynamic
assessment of telomere lengths in leukemia cells because these cells can
be tracked by the presence of the Ph chromosome during the pro-
gression of the disease. In comparison to individual telomere lengths
of 32 normal samples of this study, we show the first evidence that
some chromosome arm–specific telomeres are well maintained or even
lengthened in leukemia cells that carry the Ph chromosome. These
are common events, and the consistency across different samples shows
a nonrandom distribution of individual telomere lengths. These long
telomeres represent a new clonal event because they exist in a number
of cells that must be derived from a common progenitor origin. This
finding may yield new insights into cancer, such that the abnormal
proliferative risk of cells could be evaluated by altered telomere length
at particular chromosomes early in tumorigenesis.
Materials and Methods
Sample sources, cell culture, preparation of cytogenetic slides for
Q-FISH and Southern blot based TRF techniques are described in
Supplementary Materials and Methods. The ethics committees from
each of the institutions involved approved all research protocols and
methods. Unless the data were collected anonymously, we have ob-
tained all informed consent forms from individuals whose samples
were used in this study.
Peptide Nucleic Acid FISH
FISH was performed using a peptide nucleic acid (PNA) telomere
probe fluorescein isothiocyanate–(CCCTAA)3 (Applied Biosystems,
Foster City, CA). Hybridizations followed standard manufacturer’s
protocols with slight modifications [31,32]. Briefly, slides were left
for 24 hours at 37° C after spreading and then fixed in a 3.7% form-
aldehyde solution, followed by a proteinase K treatment. Next, the
slide preparations were denatured at 80°C for 3 minutes under a 24 ×
30-mm cover slip in the presence of 10 μl of PNA telomere probe.
Hybridization was then carried out in the dark for 30 minutes at room
temperature, followed by a posthybridization wash in 0.4× SSC con-
taining 0.3% NP-40 at 65°C for 2 minutes followed by another wash
in 2× SSC/0.1% NP-40 for 2 minutes. The slides were counterstained
with 125 ng/ml 4,6-diamidino-2-phenylindole (DAPI) mixed with
1 mg/ml of p-phenylenediamine (Sigma Aldrich, St Louis, MO). The
slides were kept in the dark for 2 days at room temperature to enhance
banding patterns on chromosomes.
Measurement of Individual Telomere Signal Intensity
After FISH, the slides were examined under an epifluorescence
microscope (Olympus BX61; Olympus America, Inc, Center Valley,
PA) and the proper metaphases were captured with a Compulog
IMAC-CCD S30 camera (MetaSystems Group, Inc, Waltham, MA).
The Isis imaging system (MetaSystems Group, Inc, Waltham, MA)
was used to process the images. The metaphase images were karyo-
typed based on the DAPI banding pattern. In the imaging system,
the telomere border selection lines were individually adjusted to mea-
sure the appropriate telomeric area. Individual telomeric signal intensi-
ties were then measured using the “Telomere Measurement” function
of the image system. Measurements were automatically corrected for
background by subtraction of the histogram maximum from each pixel
in the chromosomes. For the healthy adult sample set, we analyzed 9
to 13 cells per sample, and for the CML sample set, we analyzed 7 to
16 metaphases per sample depending on the quality of DAPI band-
ing. The specific cytogenetic marker of Ph chromosome presented as
a translocation between chromosomal 9 and 22 was confirmed by
DAPI banding in all of the metaphases in all CML samples. Fluores-
cence intensities of telomere signals were measured on both short arm
(p) and long arm (q) ends of all chromosomes from each cell. For each
specific chromosome arm, in the healthy group, we measured 650 to
656 of telomere signals from each autosome, 542 from the X chromo-
some, and 113 from the Y chromosome in a total of 328 cells; in the
CML group, we measured 620 to 667 telomeric signals from each
autosome, 492 from the X chromosome, and 129 from the Y chromo-
some in a total of 337 cells. The raw data were exported into Excel
(Microsoft Corp, Redmond, WA) for further analysis.
Analysis of Chromosome Arm–Specific Relative
Telomere Lengths
To calculate relative telomere lengths (RTLs), we followed the
system of classification of nonbanded chromosomes in the An Inter-
national System for Human Cytogenetic Nomenclature handbook [33].
In this system, the relative length for a chromosome is defined as the
length of that chromosome relative to the sum of all chromosomes in
a haploid set. Similarly, we defined RTL on a specific chromosome
arm as the ratio, expressed per thousand, of the fluorescence signal
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Figure 1. Representative images of telomere FISH in CML cases. In each row of images, two cases with long telomeres at the same
chromosome arm are shown. The names of the chromosome arms are written on the left of images. Long telomeres with intense
fluorescence signals at specific chromosome arms are indicated with red arrows in images on the left, and identification of chromosomes
with DAPI banding for the same cell is shown in black/white images on the right for each case.
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Table 1. The Comparison of the Mean of Means RTL for Each Specific Telomere in the Healthy and the CML Sample Groups.
Tel. Healthy RTL CML RTL Tel. Healthy RTL CML RTL
Mean of Means SE Mean of Means SE P (t Test) Mean of Means SE Mean of Means SE P (t Test)
1p 11.97 0.35 11.75 0.49 0.716 13p 11.31 0.29 10.86 0.56 0.486
1q 11.25 0.24 10.24 0.31 0.013 13q 12.47 0.35 12.68 0.56 0.746
2p 11.65 0.29 11.54 0.40 0.834 14p 11.42 0.35 12.15 0.66 0.335
2q 9.80 0.23 9.72 0.31 0.837 14q 11.58 0.34 11.42 0.31 0.738
3p 13.07 0.35 12.81 0.54 0.681 15p 11.36 0.29 11.47 0.63 0.870
3q 10.91 0.24 11.54 0.43 0.206 15q 11.16 0.29 10.77 0.22 0.289
4p 11.11 0.20 11.16 0.29 0.883 16p 9.34 0.22 10.78 0.36 0.001
4q 12.42 0.37 12.44 0.61 0.983 16q 10.12 0.29 10.32 0.38 0.675
5p 12.68 0.29 12.82 0.52 0.810 17p 8.72 0.26 11.13 0.34 <0.001
5q 10.65 0.28 10.99 0.38 0.480 17q 9.33 0.27 9.66 0.30 0.423
6p 10.21 0.30 10.62 0.33 0.365 18p 10.96 0.23 12.71 0.62 0.010
6q 11.64 0.25 10.96 0.32 0.101 18q 11.40 0.28 11.53 0.48 0.810
7p 10.57 0.28 10.52 0.33 0.911 19p 9.28 0.39 10.26 0.39 0.078
7q 12.09 0.27 13.00 1.05 0.403 19q 9.79 0.28 10.00 0.38 0.644
8p 11.11 0.30 11.59 0.34 0.283 20p 10.86 0.37 11.07 0.34 0.671
8q 11.07 0.28 10.68 0.32 0.362 20q 9.61 0.34 9.72 0.33 0.818
9p 10.20 0.24 11.78 0.33 <0.001 21p 11.55 0.34 9.02 0.37 <0.001
9q 9.95 0.34 10.34 0.35 0.425 21q 10.52 0.43 9.94 0.34 0.294
10p 10.97 0.30 11.97 0.31 0.023 22p 11.46 0.46 9.52 0.48 0.005
10q 10.58 0.26 11.52 0.46 0.075 22q 9.11 0.27 9.85 0.30 0.078
11p 10.72 0.38 13.01 0.52 <0.001 Xp 12.72 0.53 14.41 1.16 0.191
11q 11.51 0.31 11.48 0.33 0.941 Xq 10.15 0.36 11.06 0.42 0.108
12p 9.44 0.25 11.06 0.37 <0.001 Yp 13.95 0.89 14.47 1.31 0.700
12q 11.70 0.28 11.87 0.42 0.727 Yq 11.22 1.11 8.32 0.56 0.023
Telomere lengths at some chromosome arms with significant difference between healthy and CML groups (P < .05) are in bold.
Tel. indicates telomere.
Figure 2. Ranking mean of means RTLs for each chromosome arm in healthy and CML sample groups. (A) In the healthy sample group,
those RTLs falling in the shortest and the longest categories are colored in gray. (B) In the CML sample group, those shortest and
longest RTLs that were observed in the healthy sample group are also colored in gray, but those that were found only in the CML sample
group are colored in black. Error bars, SEM. In the graphs, RTL values are shown on the y axis. RTLs for chromosome arms (Y chromo-
some is not included) are assigned in an ascending manner on the x axis.
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intensity of an individual telomere to the sum of all signal intensities
from all telomeres in the cell being analyzed. To minimize the varia-
tion caused by random chromosome loss, cells that had lost more
than two chromosomes were excluded from this analysis, which lim-
ited the level of variation to below 5% (2/46). The mean RTL of
each specific chromosome arm from each individual sample was cal-
culated, and then the mean of means RTL within each of the two
sample groups (healthy and CML) was generated. We then analyzed
RTLs for each particular chromosome arm using three different levels
of statistical analyses. In the first level of analysis, the general distri-
bution of each mean of means of RTLs was compared between two
groups using the Student t test. In the second level of analysis, we
sorted the mean of means of RTLs into two groups, long telomeres
and short telomeres, only including those RTLs that are not signifi-
cantly different (P > .05) from the longest or the shortest RTL in a
given sample group (healthy or CML). Although the RTL at the Yq
appeared to be the shortest for the CML group and the Yp appeared
to be the longest for both healthy and CML groups, the numbers of
Y chromosomes analyzed were too low and resulted in very unequal
numbers of RTLs compared with those at other chromosomes, and
thus, the RTL at the Y chromosome was not counted. In the third
level of analysis, for each CML case, the proportion of cells that carry
Table 2. Recurrent Long RTLs in the CML and the Healthy Samples.
Chr. Arms CML Healthy
Case ID Mean RTL for the Case SE % of Cells over Cutoff Case ID Mean RTL for the Case SE % of Cells over Cutoff
4q 7 17.20 1.67 60 8 15.19 1.46 40
19 25.86 4.29 80 19 16.90 2.58 40
24 18.77 2.21 73 31 13.97 2.13 40
31 15.59 1.58 73
5p 2 16.98 2.03 40 1 14.84 1.78 40
3 21.81 2.22 53 2 14.07 1.60 50
4 14.42 2.15 40 7 14.50 1.42 40
23 14.02 1.19 45
27 19.06 2.60 80
7q 10 22.91 3.07 91 None
25 18.81 2.05 70
28 41.18 6.75 94
11p 6 14.99 1.49 62 None
15 21.19 3.87 75
16 15.84 1.88 44
20 22.04 4.29 71
13p 13 22.42 3.85 89 12 14.47 1.52 44
23 15.61 1.34 45
31 14.76 1.79 64
13q 4 17.67 2.85 40 30 14.77 1.78 40
10 21.94 3.63 73
14 22.50 4.64 88
25 14.97 1.80 60
29 14.23 1.71 40
14p 10 19.32 1.91 64 21 15.77 2.91 40
14 25.63 2.20 75
17 18.38 2.23 55
15p 5 17.06 2.12 40 None
7 16.62 1.73 53
17 22.77 2.70 82
27 13.66 1.89 40
18p 13 16.69 1.56 44 None
16 19.41 1.59 44
18 19.94 2.34 50
Xp 2 19.03 3.07 80 1 23.32 4.28 60
3 46.18 3.41 87 7 17.01 1.20 40
5 15.47 1.82 50
19 20.24 3.38 40
30 15.68 1.22 50
Ten chromosome arms with long RTL were found recurrently in the CML group, each of which was scored at least three cases. Six of these long RTLs, namely, 4q, 5p, 13p, 13q, 14p, and Xp, were
commonly observed in both CML and healthy sample groups. All of the tabulated RTLs had z values greater than two-fold and were counted in at least 40% of cells.
Chr. indicates chromosome.
Figure 3. Dot plots for z value analysis of “constitutional” long RTLs. Six specific chromosome arms, 5p, Xp, 4q, 13p, 13q, and 14p (from
top to bottom panel), with long telomeres were observed in both healthy (left images) and CML (right images) samples. Note: Each dot
represents a cell with a specific RTL. Dashed red lines indicate the cutoff (z value of 2) for detection of long telomeres. The chromosome
numbers are indicated on the x axis, and z values are on the y axis. It is considered a nonrandom event when at least 40% cells (covered
in dashed red circles) contain long telomeres at the same chromosome arms. The same description of terms and symbols in the dot
plots applies for the next two figures.
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long RTL at specific chromosome arms was determined by convert-
ing each single RTL to a z value [34]. The z value is defined as z =
(x − x¯ ) / s, where x represents the value of any single RTL in a given
cell, x¯ is the mean RTL of all telomeres in this cell, and s is its SD. A
z value of 2 was used as a cutoff, so that unusually long RTLs (those
RTLs that are greater than 2 × SD) would be scored. A nonrandom
event was thus scored when a z value for an RTL for a given chro-
mosomal arm exceeded the cutoff in at least 40% of the analyzed
cells. This percentage is derived from the commonly used standard
of Dewald et al. [35] for clinical genetics laboratories; whereas we
have previously determined empirically the analytical sensitivity of
FISH at 99% efficiency [32], analysis of at least seven metaphases
is sufficient for the detection of at least 40% cells carrying the same
aberration with a confidence level of 95%.
Results
Comparison of RTLs between Healthy and CML Groups
Using Q-FISH, we observed that very intense telomeric fluores-
cence signals that recurred at specific chromosome arms in individ-
ual CML cases (Figure 1). We calculated mean RTLs of each specific
telomere for each individual sample and the mean of means of RTLs
for the healthy sample group and the CML sample group. The re-
sults show that the mean of means RTLs ranged from 8.72 (17p) to
13.07 (3p) in the healthy sample group and from 9.02 (21p) to
14.41 (Xp) in the CML sample group. As a first level of statistical
analysis, we compared the RTL of each specific telomere in the
CML group to its counterpart in the healthy group. We found a sig-
nificant difference (P < .05, t test) between the two groups for telo-
meres on 11 chromosome arms: 4 of them, namely, 1q, 21p, 22p, and
Yq, were shorter; and 7 of them, namely, 9p, 10p, 11p, 12p, 16p,
17p, and 18p, were longer in the CML group than in the healthy
group (Table 1).
Next, as a second level of statistical analysis, we found that six RTLs
in the healthy sample group, namely, 17p, 22q, 19p, 17q, 16p, and
12p, fell into the short category because they were not significantly
different from the shortest telomere found on 17p (P > .05); and five
RTLs, namely, 3p, Xp, 5p, 13q, and 4q, fell into the long RTL category
because they were not significantly different from the longest telomere
found on 3p (P > .05) (Figure 2A). In the CML sample group, eight
RTLs, namely, 21p, 22p, 17q, 20q, 2q, 22q, 21q, and 19q, fell into
the short category when matched against the shortest telomere found
on 21p (P > .05); and nine RTLs, namely, Xp, 11p, 7q, 5p, 3p, 18p,
13q, 4q, and 14p, fell in the long category when matched against the
longest telomere found on Xp (P > .05) (Figure 2B). The shortest
RTLs at 12p, 16p, and 17p in the healthy sample group did not appear
in the short category of the CML sample group. These results are
consistent with results from the first level of analysis where these chro-
mosome arms in CML sample group showed a significant increase of
their RTLs (P ≤ 0.001; Table 1) relative to the healthy sample group.
Conversely, except for the longest RTLs at 7q, 11p, 14p, and 18p that
seemed to be specific to CML, all five long RTLs at 3p, Xp, 5p, 13q,
and 4q of the healthy sample group were also found in the long RTL
category of the CML group (Figure 2, A and B).
Long Telomeres at Specific Chromosome Arms
Because assessing the individual telomere lengths of all the CML
cases collectively could obscure important information regarding the
telomere length profile for each case, we performed a third level of
analysis by standardizing each sample set to z values to study the pro-
portion of cells with long RTLs at specific chromosome arms. Using the
z value of 2 as a cutoff for scoring long telomeres, we found that the
long RTL was a more predominant event than the short RTL in CML.
These relatively long telomeres showed a nonrandom distribution in
at least 40% of cells at specific chromosome arms or a specific profile
in healthy and CML individuals. On the basis of the criteria men-
tioned previously, we found that a total of 20 chromosome arms had
long RTLs in 27 of 32 CML cases (Table W1 and Figure W1A) versus
15 chromosome arms with long RTLs appeared in 16 of 32 healthy
samples (Figure W1B). Moreover, we found that 10 long RTLs, namely,
4q, 5p, 7q, 11p, 13p, 13q, 14p, 15p, 18p, and Xp, were more frequently
observed than other long RTLs in the CML sample group: each of these
long RTLs was repeated in at least three cases (Table 2). Six of them,
namely, 4q, 5p, 13p, 13q, 14p ,and Xp, were defined as “constitutional”
long RTLs because they were also observed in the healthy sample group
(Figure 3), but each of them was observed in no more than three healthy
cases (Table 2). The remaining four long RTLs, namely, 7q, 11p, 15p,
and 18p, appeared only in CML samples—these we defined as
“acquired” long telomeres (Table 2 and Figure 4).
We further analyzed absolute telomere lengths measured previously
by TRF [36] in 21 CML (Figure W2) and 5 healthy samples with the
RTLs measured by Q-FISH in this study. Eighteen of the 21 CML and
4 of 5 healthy cases had specific RTLs longer than the cutoff detected
by Q-FISH (Table W2). We identified some of these samples having
very sharp bands, larger than the bulk telomere smear in TRF gel (Fig-
ure 5A). Ten CML samples that showed no obvious large telomeric
bands in TRF exhibited lower percentage of cells with long RTLs (P <
.05; Table W2). For healthy samples, however, no additional bands
were found in TRF even when long RTLs at specific chromosome arms
were detected by Q-FISH (Figure 5B).
Discussion
Instead of the measurement of the average telomere length from all telo-
meres in millions of cells with the TRF in most studies, Q-FISH mea-
sures telomere fluorescence intensity on the bases of each specific
chromosome arm in a single dividing cell (Figure 1). Therefore, Q-
FISH–based individual RTL, which is derived from the proportion of
each individual telomere length in the total telomere lengths of a partic-
ular cell, is more suitable to detect the altered distribution of telomere
lengths at specific chromosome arms in each cell. It allows a unified sys-
tem that can benefit cross-platform comparisons of chromosome-specific
telomere lengths among different individuals and samples being investi-
gated in different laboratories. The analysis of the RTL refined by a variety
of statistical methods has enabled us to establish a profile of individual
telomere lengths for both healthy and CML sample groups.
It has been noticed that specific chromosome arms might have
propensity for certain telomere lengths, suggesting the existence for
chromosome-specific factors involved in telomere length regulation
[21–25]. Our findings of RTLs in healthy cells are consistent with
other reports. The telomeres at 3p, 4q, 5p, 13q, and Xp that fall into
the long telomere category in our healthy sample group (Figure 2A)
are very similar to previous reports from others. Indeed, using a dif-
ferent method, Martens et al. categorized telomeres at 3p, 4q, and Xp
as the longest telomeres [20], whereas Graakjaer et al. [37] , using a
similar approach to us, ranked telomeres at 3p, 4q, 5p, and Xp as
the longest telomeres in healthy individuals. We also found that the
RTLs of 17p, 12p, and 16p, which appeared in our short telomeres
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category (Table 1), and the shortest status of telomeres found on
17p and 12p are in agreement with one report [20] but less consistent
with another report [37]. This suggests that long telomeres might
share a common profile, implicating a higher involvement of the
chromosome-specific factors in telomere length regulation comparing
to short telomeres that show a variable distribution in human except
for 17p and 12p.
The shortest telomere 17p in the healthy population was previously
suggested to be associated with human cancers, because the p53 gene
and other potential tumor-suppressor genes are located on 17p [20,38].
Figure 4. Dot plots for z value analysis of “acquired” long RTLs. Four specific chromosome arms, 7q, 11p, 15p, and 18p, with long telomeres
were observed specifically in CML samples. The dot plots on the left of each panel show the z value analyzed for short arms (p) and the dot
plots on the right of each panel show the z value analyzed for the long arms (q).
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Figure 5. Correlation between Q-FISH, z value of RTLs and TRF for long telomeres. (A) Shown are three representative CML cases. Long
telomeres at specific chromosome arms (highlighted by arrows) were detected by Q-FISH (left panel). The z values of Q-FISH results
(middle panel) showing those cells with long telomeres at specific chromosome arms (spots covered by dashed red circles) strongly
correlate with the TRF results (right panel). The TRF detected long telomeric DNA bands (red arrows) are distinct from the main smear of
telomeric fragments. Kilobasepair sizes are shown for molecular markers and distinct long telomere bands. (B) Representative healthy
sample showing intense telomere signals at 5p and Xp in a metaphase using Q-FISH (left panel). This result is confirmed by z value
analysis of RTLs (middle panel). The TRF assay (right panel) shows a typical smear composed of telomeric fragments without any addi-
tional telomeric DNA bands.
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This so far remains unproven. In our CML sample group, RTLs of 17p,
12p and 16p were significantly longer than their healthy counterparts
(P ≤ 0.001; Table 1), although they did not rank as “long” in CML. The
increase in length of these RTLs in CML means that short telomeres
at these chromosome arms might be kept in check by mechanisms of
telomere length maintenance. Although biased elongation of short telo-
meres through either a telomerase-dependent or recombination-based
mechanism has previously been reported in yeast and mouse models
[39,40], only recently has this event been observed in human cells
[28], notably for short telomeres on 17p and Xp/Yp. However, these re-
sults were observed in cell lines that were transduced with components
of telomerase, such as the telomerase reverse transcriptase (hTERT).
They might have undergone many cell divisions in vitro and thus
may only reflect the result of late stage of cell proliferation. In CML,
however, loss of 17p due to the formation of isochromosome 17q is
frequently observed in the blastic crisis stage. This appearance may
imply that one of homologous 17p with the long telomere could play
a role to protect the remaining copies of essential genes on this chro-
mosome during the late stage of the disease. In short, telomere length
homeostasis, often seen as a preference by telomerase for short telo-
meres in vitro, might not reflect what occurs in vivo especially in a dis-
ease state like CML.
Our detailed analysis of telomere length distribution at the cellular
level revealed the presence of a clonal event exhibiting long telomeres
at specific chromosome arms in CML samples. Ten chromosome arms
with long RTLs were recurrently observed in at least three CML cases
(Table 2); six of them (4q, 5p, 13p, 13q, 14p, and Xp) also represented
long RTLs in healthy samples in lower frequencies (Table 2 and Fig-
ure 3), which we termed constitutional long telomeres. The remaining
four long RTLs (7q, 11p, 15p, and 18p) were specific only to CML
samples, which were defined as acquired long telomeres (Table 2 and
Figure 4). Some of these long telomeres were not simple relatively long
but were long in absolute terms, as demonstrated by TRF experiments
(Figure 5 and Figure W2). This finding suggests that some chromo-
some arm–specific telomeres that were originally long in the premalig-
nant state may have undergone preferential elongation once leukemia
has initiated, a failsafe mechanism kicks in, which protects the cell
from the erosion of chromosomal ends that occurs during excessive cell
proliferation. Two particular telomeres, Xp and 5p, stand out in this
regard. In CML, significantly longer Xp and 5p telomeres were ob-
served at higher frequency in comparison to the healthy group. It is
known that only one X chromosome is transcriptionally active in mam-
malian cells, whereas the other is silent, a process known as X chromo-
some inactivation [41]. Thus, there is added incentive for the cell to
protect the single active X chromosome from telomere shortening.
And this is precisely what was observed previously: the rate of telomere
shortening in the inactivated X chromosome is higher than that ob-
served for the active X chromosome [42]. In the case of chromosome
arm 5p, it was determined that the gene encoding hTERT, the main
component of telomerase, is located at the very end of chromosome
5p (5p15.33) [43,44]. It thus raises the possibility that telomere posi-
tion effects could be involved in the regulation of the hTERT gene
because genes placed near the long telomeres are often repressed [43].
This could be essential in normal cells because the expression of hTERT
might be downregulated by the long telomere of 5p and thus ensure
the normal telomere shortening to initiate cell senescence. However,
these long telomeres in leukemia seem associated with unregulated
cellular proliferation as we observed at CP of CML samples. This
phenomenon remains an interesting subject for further study on what
mechanisms are involved in the selective telomere maintenance and
what roles these specific long telomeres play in leukemia cells.
The acquired long telomeres observed only in the CML group might
correlate with frequently observed chromosome abnormalities in many
types of leukemia, for example, deletion of chromosome 7 or 7q and
rearrangement of chromosome 11 [45–48]. A study of a case of acute
lymphoblastic B-cell leukemia demonstrated a clear association be-
tween the presence of Ph-positive cells and telomere elongation on one
homologous 11q and that elongation of this telomere could be before
the generation of the Ph chromosome [49]. Therefore, specific telo-
mere lengthening served as a marker for clonal selection. A recent study
confirmed that telomeres on both arms of chromosome 7 in cells dis-
playing monosomy 7 were longer when compared with cells with nor-
mal karyotypes in patients with myelodysplastic syndrome (MDS)
[50]. From these studies and our findings in CML, we propose that these
long telomeres might influence on cellular fate by protecting specific
chromosomes, conferring a proliferative advantage or tumorigenic prop-
erties to specific cells, resulting in clonal expansion and the associated
disease state.
Telomere shortening has been shown as one of the stress triggers of
cellular senescence through a pathway that involves ATM, p53, and
p21 [51]. In a previous study using human senescent fibroblasts, it
was proposed that telomere-initiated senescence reflects a DNA damage
checkpoint response that is activated with a direct contribution from
dysfunctional telomeres [52]. As observed by Zou et al. [53] in cultured
BJ fibroblasts, chromosome-specific short telomeres were associated
with telomere-initiated senescence at near-senescent stage (PD 83).
We found an overlap between the shortest telomeres in CML and
senescent BJ cells, such as 21p; other short telomeres we identified were
specific for our CML samples. In Zou’s study, they have also identified
telomeres that were rarely shortened that are mostly consistent with the
constitutional and acquired long telomeres that we observed in CML
(e.g., 5p, 7q, 11p, 13q, 17p, etc.). The similarities between our mea-
surements and Zou’s indicate that the change in telomere length is
indeed not a random choice; whereas the difference between the telo-
mere profiles of CML and senescent BJ cells suggests that there might
be key chromosomes required for bypassing the cellular senescence
during malignant transformation, if not due to the difference in cell
type alone. Because some of these long telomeres were also observed
in normal cell populations and that they appeared mostly at CP in
CML, we speculate that this clonal event of specific telomere main-
tenance might have occurred at an early stage of leukemogenesis. If it
is confirmed later, this new event could serve as an indicator to in-
vestigate susceptible or risk factors of tumor- and aging-related diseases
in human.
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Supplementary Materials and Methods
Preparation of Samples
Specimens of cryopreserved blood/bone marrow from 22 CML
patients were obtained from the Québec Leukemia Cell Bank, and
cytogenetic slides from 10 CML patients were obtained from the
Center for Stem Cell Research and Application of Union Hospital in
Huazhong University of Science and Technology (China). All CML
samples (13 males and 19 females; median age, 44 years) carrying Ph
chromosome were taken from patients at diagnosis. Except for one
patient who was in the clinically defined accelerated phase (AP), all
others were in chronic phase (CP). About 5 to 10 million cells of each
sample from the Cell Bank were cultured in a 5-ml MarrowMax
medium (Invitrogen, Ontario, Canada) containing 20% fetal bovine
serum for 48 hours. For controls, metaphases obtained from lympho-
blasts that were stimulated by phytohemagglutinin from 72-hour
cultured peripheral blood were obtained from 32 healthy individuals
(11 males and 21 females; median age, 30 years). After harvesting,
the cells were suspended in a methanol/acetic acid (3:1) fixative solu-
tion, and 10 μl of fixed nuclear suspension was spread onto cleaned
slides in a modified environmental control unit Thermotron (CDS-5,
Amsterdam, Holland), where temperature and relative humidity re-
mained constant at 22°C and 55%, respectively.
Assessment of Physical Telomere Length with TRF
The physical telomere length was measured using the Telo-
TAGGG Telomere Length Assay kit (Roche Applied Science, CA)
following the manufacturer’s protocol. Briefly, DNA was extracted
using the standard method of phenol-chloroform, and 1.5 μg of
DNA was digested using HinfI and Ras restriction enzymes. The
digested DNA was run in electrophoresis with 0.7% agarose gel
and then transferred on a nylon membrane. The membrane was
hybridized with digoxigenin-labeled (CCCTAA)3 DNA probe and
exposed to an x-ray film. The telomere size was measured with
Image J software (National Institutes of Health, Bethesda, MD).
Table W1. General Information of 32 CML Samples with Scored Long Telomeres at Specific Chromosome Arms.
Case ID Age (years) Sex Tissue Long Telomeres Case ID Age (years) Sex Tissue Long Telomeres
1 45 M PB None 17 45 F BM 14p, 15p
2 26 F BM 5p, 12p, Xp 18 83 F BM 18p
3 45 M PB 5p, Xp 19 40 M BM 4q, Xp
4 45 F BM 5p, 13q 20 39 F BM 11p
5 64 F PB 15p, Xp 21 53 M BM 3p, 18q
6 18 M PB 11p, 12q, 22p 22 32 F PB None
7* 44 F BM 4q, 15p 23 24 M BM 1p, 5p, 13p, Yp
8 35 F BM None 24 40 F BM 4q
9 50 F BM 12q 25 27 M BM 3q, 7q, 13q
10 38 F BM 7q, 13q, 14p 26 35 F BM None
11 68 F BM None 27 47 M BM 5p, 15p
12 61 F BM 1p 28 30 M BM 7q
13 44 M PB 13p, 18p 29 52 M BM 13q
14 55 M PB 13q, 14p 30 20 F BM 10q, Xp
15 33 F BM 11p 31 47 M BM 4q, 13p, 20p
16 57 F BM 11p, 18p 32 35 F BM 3p
*All samples were from the chronic phase except case 7, which was in the accelerated phase. BM = bone marrow; PB = Peripheral blood.
Figure W1. Plots of distribution of long RTLs at specific chromosomes for healthy and CML sample groups. (A) All 32 healthy samples
are shown. (B) Twenty-seven of 32 CML samples showing at least 40% cells with long telomeres at certain chromosome arms are
shown. In each graph, the percentage (y axis) of cells with long telomeres is presented as colored bars (p arms are in the upper panel
and q arms are in the lower panel, and chromosome numbers are shown in the x axis between upper and lower panels). The occurrence
of at least 40% of cells (marked by dashed red line) containing long RTLs (z values greater than two-fold) at the same chromosome arm
is defined as a nonrandom event. In CML cases, these long telomeres reflect a clonal event.
Figure W2. Telomere lengths examined with TRF in 21 CML and 5 healthy samples. (A) Some CML samples show uncommon telomere
fragments, which appear as fuzzy or sharp telomeric DNA bands in a greater physical length (pointed with arrows) distinct from those
short telomere fragments that are distributed as smears in the gel. (B) The TRF results for five healthy samples are shown, and no additional
telomeric DNA bands can be seen even in the cases that some long RTLs were observed at specific chromosome arms in 40% or more of
cells, for example, Xp in the case 1, 9q in the case 3, 6q in the case 4, and 22p in the case 30. The case ID is on the top of each lane of the
panels, and the molecular markers (M) in kilobasepair are labeled at the left side of the panels. Note: Images in this figure are cropped from
different times of TRF tests. They are reorganized by the order of ID numbers and aligned by the size markers as the ones shown in the left
lanes. It is to show the presence or absence of additional DNA bands as long telomeres for different samples in the gel.
Table W2. Comparison of Long RTLs between CML Cases with and without Additional Distinct DNA Bands in TRF.
With Additional Telomere Bands Without Additional Telomere Bands
Case ID Chr. Arms RTL % of Cells with the Longest RTL Case ID Chr. Arms RTL % of Cells with the Longest RTL
3 Xp 46.2 87 2 Xp 19.0 80
10 7q 22.9 91 4 13q 17.7 40
12 1p 20.1 50 5 15p 17.1 40
13 13p 15.6 89 6 12q 18.7 54
15 11p 21.2 75 7 15p 16.6 53
16 18p 19.4 44 9 12q 15.1 42
17 15p 22.8 82 14 14p 25.6 75
21 3p 26.9 100 18 18p 19.9 50
19 4q 25.9 80
20 11p 22.0 71
The longest RTLs detected by Q-FISH in 18 CML samples are classified into two groups according to the visibility of additional bands of the long telomeric DNA in TRF tests. It shows that these
additional bands in TRF are significantly associated with the percentage of cells (P < .05, t test) but not with the value of RTL (P = .17, t test) for the longest telomere in each sample detected by Q-FISH.
